Skip to main content
Log in

Ibandronate improves hyperphosphatemia in dialysis patients with hyperparathyroidism

  • Letter to the editor
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • R Bergner K Dill D Boerner M Uppenkamp (2002) ArticleTitleElimination of intravenously administered ibandronate in patients on haemodialysis: a monocentre open study. Nephrol Dial Transplant 17 1281–1285

    Google Scholar 

  • D Lee K Kurokawa (1991) Phosphorous metabolism physiology M Maxwell C Kleeman R Narins (Eds) Clinical disorders of fluid and electrolyte metabolism Panamericana Buenos Aires 224–228

    Google Scholar 

  • F Llach (1996) Renal osteodystrophy C Jacobs C Kjellstrand K Koch J Winchester (Eds) Replacement of Renal Function by Diálisis Kluwer Academic Publisher Dordrecht 1203

    Google Scholar 

  • Fernandez E. Cardiovascular role of phosphorous. www./uninet./edu/cin2003/conf/fernandez/fernandez.htlm.

  • J Delmez M Kaye (2001) Bone disease J Daugirdas P Blake T Ing (Eds) Handbook of dialysis Lippincott Williams & Williams Philadelphia 530–545

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C.G Musso.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Musso, C., Guelman, R., Varela, F. et al. Ibandronate improves hyperphosphatemia in dialysis patients with hyperparathyroidism. Int Urol Nephrol 36, 625–627 (2004). https://doi.org/10.1007/s11255-004-2077-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-004-2077-5

Keywords

Navigation